Salvage Therapy with Bortezomib Plus Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma: Initial Results of a Phase II Trial (Alliance/CALGB 50501)
- Citation:
- ASH Annual Meeting Abstracts vol 120 (21) -3696
- Meeting Instance:
- ASH 2012
- Year:
- 2012
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2054
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- V. A. Morrison S.-H. Jung J. Johnson A. Lacasce K. A. Blum N. L. Bartlett B. D. Cheson
- Networks:
- Study
- CALGB-50501
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: